TYK Medicines (HKSE:02410) Cash And Cash Equivalents : HK$464.93 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is TYK Medicines Cash And Cash Equivalents?

TYK Medicines's quarterly cash and cash equivalents declined from Mar. 2024 (HK$149.05 Mil) to Jun. 2024 (HK$113.08 Mil) but then increased from Jun. 2024 (HK$113.08 Mil) to Dec. 2024 (HK$464.93 Mil).

TYK Medicines's annual cash and cash equivalents increased from Dec. 2022 (HK$101.36 Mil) to Dec. 2023 (HK$204.35 Mil) and increased from Dec. 2023 (HK$204.35 Mil) to Dec. 2024 (HK$464.93 Mil).

TYK Medicines Cash And Cash Equivalents Historical Data

The historical data trend for TYK Medicines's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TYK Medicines Cash And Cash Equivalents Chart

TYK Medicines Annual Data

Trend

Dec22

Dec23

Dec24

Cash And Cash Equivalents

101.36

204.35

464.93

TYK Medicines Quarterly Data
	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24	Dec24
Cash And Cash Equivalents	Get a 7-Day Free Trial			-	204.35	149.05	113.08	464.93

TYK Medicines Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

TYK Medicines (HKSE:02410) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

TYK Medicines Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of TYK Medicines's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

TYK Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TYK Medicines Inc (HKSE:02410) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.277 Longlan Road, 8th Floor, Building T2, China Eastern Binjiang Center, Xuhui District, Shanghai, CHN

Website

https://www.tykmedicines.com

TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with 12 drug candidates, including Core Product TY-9591, seven products in the clinical stage, and four products in the preclinical stage or early clinical development stage.

Executives

Nan Jing Yi Da Tou Zi Guan Li You Xian Gong Si
Nan Jing Yi Da Zi Ben Guan Li Qi Ye You Xian He Huo
Jiang Su Yi Da Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Wu Yusheng	2201 Interest of corporation controlled by you
Zhu Julia Ming	2202 Interest of your spouse
Zheng Zhou Tai Ji Hong Nuo Yi Yao Gu Fen You Xian Gong Si	2101 Beneficial owner
Zhang Xing Li Yuan Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
He Chao	2201 Interest of corporation controlled by you
Bei Jing Hou Ji Jing Qiao Chuang Ye Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Rong Chen Hou Ji Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Zhang Xing Xing Zhang Chan Ye Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner

TYK Medicines Headlines

No Headlines